67306 Federal Register / Vol. 83, No. 248 / Friday, December 28, 2018 / Notices 

and analysis conducted by ORI in its 

oversight review, ORI found that Dr. 

Venkata Sudheer Kumar Ramadugu, 

former postdoctoral scientist in the 

Department of Chemistry, UM, engaged 

in research misconduct in research 

supported by NIGMS, NIH, grant R01 

GM084018 and NIA, NIH, grant R01 

AG048934. 

ORI found that Respondent engaged 

in research misconduct by knowingly 

and intentionally falsifying and/or 

fabricating data reported in the 

following published papers and poster 

presentation: 

• Chemical Communications 

53(78):10824–10826, 2017 (hereafter 

referred to as ‘‘Chem. Comm. 2017’’). 

• Angewandte Chemie-International 

Edition 56(38):11466–11470, 2017 

(hereafter referred to as ‘‘Angewandte 

Chemie-International Edition 2017’’). 

• Angewandte Chemie-International 

Edition 57(5):1342–1345, 2018 

(hereafter referred to as ‘‘Angewandte 

Chemie-International Edition 2018’’). 

• Polymer macrodiscs for solid-state 

NMR structural studies on aligned lipid 

bilayers.’’ Presented at the 58th 

Experimental Nuclear Magnetic 

Resonance Conference in Pacific Grove 

(Asilomar), California, March 25–30, 

2017 (hereafter referred to as the 

‘‘ENMRC Poster 2017’’). 

ORI found that Respondent 

intentionally and knowingly falsified 

and/or fabricated NMR spectroscopy 

data for structure and dynamics of 

nanodiscs in thirteen (13) figure panels 

included in three (3) published papers 

and one (1) poster presentation by 

manipulating previously generated 

NMR data from unrelated experiments 

to falsely represent NMR spectra for 

completely different experiments. 

Specifically, Respondent falsified and/ 

or fabricated NMR spectra in: 

• Chem. Comm. 2017. 

— Figure 2A. 

— Figure 2B, top and bottom panels. 

— Figure 3, bottom two panels of the 

right most column. 

— Figure S4, second, third, and the 

bottom panels from the top. 

• Angewandte Chemie-International 

Edition 2017. 

— Figures 4E and 4F. 

• Angewandte Chemie-International 

Edition 2018. 

— Figure 4B. 

• ENMRC Poster 2017. 

— Figure labelled ‘‘Magnetic 

Alignment of Macrodiscs,’’ bottom two 

panels of the right most column. 

Dr. Ramadugu entered into a 

Voluntary Exclusion Agreement 

(Agreement) and voluntarily agreed for 

a period of five (5) years, beginning on 

December 4, 2018: 

(1) Because he also made a false 

statement in his first admission that no 

other data were affected in his papers, 

to exclude himself from any contracting 

or subcontracting with any agency of the 

United States Government and from 

eligibility for or involvement in 

nonprocurement programs of the United 

States Government referred to as 

‘‘covered transactions’’ pursuant to 

HHS’ Implementation (2 CFR part 376) 

of OMB Guidelines to Agencies on 

Governmentwide Debarment and 

Suspension, 2 CFR part 180 (collectively 

the ‘‘Debarment Regulations’’); and 

(2) to exclude himself from serving in 

any advisory capacity to PHS including, 

but not limited to, service on any PHS 

advisory committee, board, and/or peer 

review committee, or as a consultant. 

Wanda K. Jones, 

Interim Director, Office of Research Integrity. 

[FR Doc. 2018–28139 Filed 12–27–18; 8:45 am] 

BILLING CODE 4150–31–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

[Document Identifier: OS–0990–0460] 

Agency Information Collection 

Request; 30-Day Public Comment 

Request 

AGENCY: Office of the Secretary, HHS. 

ACTION: Notice. 

SUMMARY: In compliance with the 

requirement of the Paperwork 

Reduction Act of 1995, the Office of the 

Secretary (OS), Department of Health 

and Human Services, is publishing the 

following summary of a proposed 

collection for public comment. 

DATES: Comments on the ICR must be 

received on or before January 28, 2019. 

ADDRESSES: Submit your comments to 

OIRA_submission@omb.eop.gov or via 

facsimile to (202) 395–5806. 

FOR FURTHER INFORMATION CONTACT: 

Sherrette Funn, Sherrette.Funn@hhs.gov 

or (202) 795–7714. When submitting 

comments or requesting information, 

please include the document identifier 

0990–0460–30D and project title for 

reference. 

SUPPLEMENTARY INFORMATION: Interested 

persons are invited to send comments 

regarding this burden estimate or any 

other aspect of this collection of 

information, including any of the 

following subjects: (1) The necessity and 

utility of the proposed information 

collection for the proper performance of 

the agency’s functions; (2) the accuracy 

of the estimated burden; (3) ways to 

enhance the quality, utility, and clarity 

of the information to be collected; and 

(4) the use of automated collection 

techniques or other forms of information 

technology to minimize the information 

collection burden. 

Title of the Collection: Office of 

Adolescent Health Pregnancy 

Assistance Fund (PAF) Performance 

Measures Data Collection, FY2018– 

FY2020. 

Type of Collection: Revision. 

OMB No.: 0990–0460. 

Abstract: The Office of Adolescent 

Health seeks a revision of the Pregnancy 

Assistance Fund (PAF) performance 

measures data collection. A new cohort 

of 23 PAF grantees was funded in 2018. 

PAF provides funding to States and 

Tribes to provide expectant and 

parenting teens, women, fathers and 

their families with a seamless network 

of supportive services to help them 

complete high school or postsecondary 

degrees; and to help states improve 

services to expectant females who 

experience intimate partner violence or 

stalking, Additional measures have been 

proposed for addition to the existing 

menu of approved measures. A 3 year 

clearance period is requested. The 

respondents would be the 23 state and 

tribal entities receiving PAF awards in 

2018. Data would be collected annually. 

ESTIMATED ANNUALIZED BURDEN TABLE

Type of respondent Number of 

respondents 

Number 

responses per 

respondent 

Average 

burden per 

response 

(in hours) 

Total burden 

hours 

All PAF Grant Recipients (Training Form) ....................................................... 23 1 15/60 6 

All PAF Grant Recipients (Partners Sustainability Form) ................................ 23 1 210/60 81 

All PAF Grant Recipients (Reach Demographics Form) ................................. 23 1 637/60 244 

All PAF Grant Recipients (Core Services) ...................................................... 23 1 9 207 

All PAF Grant Recipients ( ) ............................................................................ 23 1 5 115 


amozie on DSK3GDR082PROD with NOTICES1
Federal Register / Vol. 83, No. 248 / Friday, December 28, 2018 / Notices 67307 

ESTIMATED ANNUALIZED BURDEN TABLE—Continued 

Type of respondent Number of 

respondents 

Number 

responses per 

respondent 

Average 

burden per 

response 

(in hours) 

Total burden 

hours 

PAF Grantees (Form for Grantees funding State Attorney General offices) .. 2 1 2 4 

Total .......................................................................................................... 23 1 ........................ 657 

Terry Clark, 

Office of the Secretary, Asst. Paperwork 

Reduction Act Reports Clearance Officer. 

[FR Doc. 2018–28227 Filed 12–27–18; 8:45 am] 

BILLING CODE 4168–11–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Indian Health Service 

Office of Urban Indian Health 

Programs; 4-in-1 Grant Programs 

Key Dates 

Application Deadline Date: February 

15, 2019. 

Earliest Anticipated Start Date: April 

1, 2019. 

Proof of Non-Profit Status Due Date: 

February 15, 2019. 

I. Funding Opportunity Description 

Statutory Authority 

The Indian Health Service (IHS) 

Office of Urban Indian Health Programs 

(OUIHP) is accepting applications for 

competitive grants for the Fiscal Year 

(FY) 2019 4-in-1 for Urban Indian 

Organizations. This program is 

authorized under the Snyder Act, 25 

U.S.C. 13, Public Law 67–85, and Title 

V of the Indian Health Care 

Improvement Act (IHCIA), Public Law 

94–437, as amended, specifically the 

provisions codified at 25 U.S.C. 

1653(c)–(e) (authorizing grants for 

health promotion and disease 

prevention services, immunization 

services and mental health services), 

and § 1660a (authorizing grants for 

alcohol and substance abuse related 

services). This program is described in 

the Catalog of Federal Domestic 

Assistance (CFDA) under 93.193. 

Background 

In the late 1960s, Urban Indian 

community leaders began advocating at 

the local, State and Federal levels to 

address the unmet health care needs of 

Urban Indians, and requested health 

care services and programs. These 

efforts resulted in an increase of 

preventative, medical, and behavioral 

health services, but there was growing 

recognition of challenges preventing 

Urban Indians in seeking health care 

services. To address these barriers, 

advocacy focused on the development 

of culturally appropriate activities that 

were unique to the social, cultural and 

spiritual needs of American Indians and 

Alaska Natives residing in urban 

settings. Programs developed at that 

time were staffed by volunteers in 

storefront settings with limited budgets 

offering primary care and outreach and 

referral-type services. 

In response to efforts of the Urban 

Indian community leaders, Congress 

appropriated funds in 1966, through the 

IHS, for a pilot urban clinic in Rapid 

City, South Dakota. In 1973, Congress 

appropriated funds to study unmet 

Urban Indian health needs in 

Minneapolis, Minnesota. The findings 

of this study documented cultural, 

economic, and access barriers to health 

care and led to congressional 

appropriations under the Snyder Act to 

support emerging Urban Indian clinics 

in several Bureau of Indian Affairs 

relocation cities, e.g., Seattle, San 

Francisco, Tulsa, and Dallas. In 1976, 

Congress passed the IHCIA, Public Law 

94–437, establishing the Urban Indian 

health program under Title V. Congress 

reauthorized the IHCIA in 2010 under 

Public Law 111–148 (2010). This law is 

considered health care reform 

legislation to improve the health and 

well-being of all American Indians and 

Alaska Natives, including Urban 

Indians. Title V-specific funding is 

authorized for the development of 

programs for Urban Indians residing in 

urban areas. These areas include health 

promotion and disease prevention (HP/ 

DP) services, immunization services, 

alcohol and substance abuse related 

services, and mental health services, 

hereafter referred to as ‘‘4-in-1,’’ health 

programs or services. 

Purpose 

The purpose of this IHS grant 

announcement is to award funding to 

Urban Indian Organizations to ensure 

the highest possible health status for 

Urban Indians. Funding will be used to 

support the 4-in-1 health program 

objectives. Specifically, the four health 

programs are: (1) HP/DP services, (2) 

immunization services, (3) alcohol and 

substance abuse related services, and (4) 

mental health services. These programs 

are integral components of the IHS 

health care delivery system. Funds from 

this effort will ensure that 

comprehensive, culturally acceptable 

personal and public health services are 

available and accessible to Urban 

Indians. 

II. Award Information 

Type of Awards 

Grants. 

Estimated Funds Available 

The total amount of funding 

identified for FY 2019 is approximately 

$8.3 million. Individual award amounts 

are anticipated to be between $50,000 

and $650,000. Total funding available 

for competitive new and competing 

continuation awards issued under this 

announcement is subject to the 

availability of appropriations and 

budgetary priorities of the Agency. The 

IHS is under no obligation to make 

awards that are selected for funding 

under this announcement. 

New applicants are eligible to apply 

for funding, up to $200,000, under this 

funding announcement. Current 4-in-1 

grantees are eligible to apply for 

competing continuation funding under 

this announcement and must 

demonstrate that they have complied 

with previous terms and conditions of 

the 4-in-1 grant in order to receive 

funding under this announcement. 

Current 4-in-1 grantees may request 

annual funds up to the total cost amount 

approved in the last noncompeting 

award. 

Anticipated Number of Awards 

Approximately 39 grants will be 

issued under this program 

announcement. 

Project Period 

The project period is for three years. 


amozie on DSK3GDR082PROD with NOTICES1